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Abstract
Introduction
Population health surveys are used to record person-reported outcome measures for chronic health
conditions and provide a useful source of data when evaluating potential disease burdens. The
reliability of survey-based prevalence estimates for chronic diseases is unclear nonetheless. This
study applied methodological triangulation via a data linkage method to validate prevalence of
selected chronic conditions (angina, myocardial infarction, heart failure, and asthma).
Methods
Linked healthcare records were used for a combined cohort of 11,323 adults from the 2013 and 2014
sweeps of the Welsh Health Survey (WHS). The approach utilised consented survey data linked to
primary and secondary care electronic health record (EHR) data back to 2002 within the Secure
Anonymised Information Linkage (SAIL) Databank.
Results
This descriptive study demonstrates validation of survey and clinical data using data linkage for
selected chronic cardiovascular conditions and asthma with varied success. The results indicate
that identifying cases for separate cardiovascular conditions was limited without specific medication
codes for each condition, but more straightforward for asthma, where there was an extensive list of
medications available. For asthma there was better agreement between prevalence estimates based
on survey and clinical data as a result.
Conclusion
Whilst the results provide external validity for the WHS as an instrument for estimating the burden
of chronic disease, they also indicate that a data linkage appproach can be used to produce compa-
rable prevalence estimates using clinical data if a defined condition-specific set of clinical codes are
available.
Introduction
Population health surveys have been used to record informa-
tion on chronic conditions and self-reported health for many
years [1]. For well-developed healthcare systems, patient re-
ported health surveys provide a useful source of information for
health research when this information is not collected within
routine administrative data. Measures of chronic conditions
from health surveys provide an indication of disease burden
and potential need for health services for various conditions
including those which carry a greater risk of mortality, for in-
stance cardiovascular disease [2].
For many years, the Welsh Health Survey (WHS) was the
main instrument for point-in-time measures of self-reported
health and morbidity in Wales. In 2015 the WHS was incor-
porated into the revamped National Survey for Wales (NSW),
but it could be argued that alternative methods of estimating
chronic disease prevalence now exist. The warehousing of fairly
comprehensive clinical datasets (derived from electronic health
records (EHR)) from primary and secondary care in a secure
research environment as provided by the Secure Anonymised
Information Linkage (SAIL) Databank means that prevalence
of diseases could potentially be measured on a whole popu-
lation basis. The utility of the SAIL Databank has been ex-
panded by storage of both healthcare and non-clinical data,
such as survey data from the WHS and the NSW, in the same
environment and with the potential to link these datasets to-
gether. Following these developments, it is now possible to
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address these research questions:
1. How do counts of chronic disease derived from clinical
EHR compare with self-reported counts from the Welsh
Health Survey?
2. Where a disease register does not exist, is it feasible
to use an algorithm to identify prevalence of specific
chronic conditions from EHR?
This study seeks to address these questions. Although not
completely comprehensive (see with reference to GP data be-
low), for purposes of this study clinical data are considered to
be the gold standard against which health survey data may be
validated. This is because they are collected on a consistent
basis across the jurisdiction of Wales and recorded by profes-
sional staff rather than hand-written by survey recipients (as
was the case with the WHS). In addition, clinical data are
recorded for a comprehensive range of morbidities compared
to the limited range which can be captured by a population
health survey.
Objectives
This study aims to exploit the opportunity provided by co-
location of anonymised survey- and clinical data to investi-
gate how well self-reported survey data performed compared
to the clinical data being made available in the SAIL databank.
A secondary objective is to explore whether for some chronic
conditions prevalence estimates could more feasibly be made
using clinical data. A third objective is to provide a method-
ological development step towards investigation of many other
conditions now recorded in the WHS successor, the NSW. Fi-
nally, we hope to contribute to the development of population
data science through a complete presentation of the method
used to produce these research findings.
This study has been made possible by the SAIL Databank,
which provides the ability to link various data sources securely
and anonymously in a privacy-protecting platform. Provision
to enable informed consent to data linkage was made in the
WHS from 2013 onwards so that survey-related research ques-
tions can be addressed using anonymised data, which is part of
the national e-health records research infrastructure for Wales
[3, 4].
Methods
This is a descriptive cross-sectional study, which applies
methodological triangulation to anonymised data from the
WHS for 2013 and 2014, with clinical data from 2002 to 2014
in a secure environment. Combining datasets in this way could
provide the basis for further analysis of chronic conditions and
wellbeing as recorded by the WHS.
Condition Selection
The incidence of chronic conditions such as stroke and vari-
ous cancers is well established through national registries [5,
6]. Consequently, the data linkage and triangulation method
was applied to a subset of chronic conditions that are present
in the survey data and for which registries do not currently
exist in Wales. The conditions selected for analysis included
‘angina’, ‘myocardial infarction’ (hereafter referred to as ‘heart
attack’, as recorded in the WHS), ‘heart failure’, and ‘asthma’
as recorded via separate tick boxes on the WHS form. Ques-
tion syntax varied so that respondents were asked if they had
‘ever been treated for’ heart attack, and are ‘currently being
treated for’ asthma, angina and heart failure.
Sample Population – survey data
The WHS samples were selected from the small user version
of the Postcode Address File (PAF) provided by Royal Mail.
Addresses were randomly sampled and stratified across Wales,
with the aim of a minimum sample of 600 adults across each
local authority area. These were combined into a single dataset
for further analysis. For selected households the WHS also
sampled children but consent to linkage was not obtained from
them. As a result, no data for children were obtained for this
study.
All data were anonymised through a standard split file ap-
proach when being acquired into the SAIL Databank. Deter-
ministic matching and validation to a unique identifier (known
as an Anonymised Linking Field or ‘ALF’) was applied by the
NHS Wales Informatics Service (NWIS) before acquisition into
the SAIL Databank.
Linking to clinical data
Survey records that were not matched to a unique identifier
by the anonymization process were removed from the survey
dataset at the outset. To maximise the sample size both good
and ‘fuzzy’ matches (where it was less clear that records re-
lated to the same person) were retained. The two-year WHS
analytic sample was then used to select corresponding records
from clinical datasets, based on matching unique identifiers
contained in each.
The healthcare data linked for this study were the hos-
pital admission data (Patient Episode Database for Wales
(PEDW)), welsh population spine of registrations and resi-
dence history (Welsh Demographics Service Dataset (WDSD))
and the Welsh Longitudinal General Practice data (WLGP).
Records were matched in hospital admission data as far back
as 2002 and GP event data back to 2010. Records were also
matched with central registry data, as the GP data used cov-
ered only around 80% of General Practitioner (GP) surgeries
in Wales. In this way any undercount in prevalence from the
GP data could be assessed. Specialist physician data were not
used as they were not available for this study.
These datasets were linked and combined using SQL DB2
(IBM, Portsmouth, UK) as shown in Figure 1, resulting in a
‘platform file’ containing all relevant data. In this platform
file matched records for all survey respondents (n =11,323)
were retained for onward analysis of wellbeing for those with
and without chronic conditions, including those without any
clinical events or diagnoses.
Identifying chronic conditions
Indication of diagnoses and/or treatments related to ‘angina’,
‘heart attack’, ‘heart failure’ and ‘asthma’ were identified in
the clinical data using lists of hospital diagnosis (ICD-10) and
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GP event (Read) codes (see Supplementary Appendices 1 and
2). For each condition, lists of ICD and Read codes were
created based on information from respective online reference
sources [7, 8]. For cardiovascular conditions the lists were de-
veloped following discussion with a clinician specialising in car-
diovascular disease, with particular advice provided on whether
GP event codes related exclusively to heart attack or heart
failure. For asthma the list of codes was supplemented with
an extensive list of medications used to identify cases in the
Cognitive development Respiratory Tract Illness and Effects of
eXposure (CORTEX) project [9].
All cases of the selected chronic conditions identified were
tagged using the lists of ICD and Read codes. For cardio-
vascular conditions, cases were tagged where clinical codes
were solely related to one condition, and not tagged where
they could relate to more than one condition - for example
instances of oedema which can be related to pregnancy, be-
ing overweight, or kidney problems as well as heart failure.
Similarly, codes for prescription medications were not used to
tag cases of cardiovascular conditions as some medications are
used to treat both heart attack and heart failure. In effect an
approach was taken to avoid mis-classifying conditions another
which prioritised specificity over sensitivity.
All identified cases were tagged in the detailed dataset
based on any occurrence of relevant codes as evidence of
having been treated for the selected condition. As indicated
above, WHS question wording varied so that for heart attack
(which asks about ever having been treated), any occurrence
of relevant GP event and diagnosis codes were used, whilst
for angina, heart failure and asthma (which ask about current
treatment), occurrence of relevant GP event and diagnosis
codes in the 12 months prior to interview were used. Sum-
mary counts of relevant events and diagnoses for each survey
respondent were extracted using Structured Query Language
(SQL) DB2. Further analysis was then carried out in SAS
version 9.4 (SAS Institute Inc, Cary, NC) and SPSS 26 (IBM
Corp, Armonk, NY) in the SAIL Databank secure environment.
Data Analysis
A binary flag was derived from responses to relevant survey
questions and used to identify cases from the survey data.
Survey respondents were identified as cases for the selected
chronic conditions based on having had at least one event or
diagnosis recorded in the clinical data. Contingency matrices
were created, based on clinical data as the ‘gold standard’
against which survey data would be compared. The aim of
this approach was to establish groups from these contingency
matrices (‘true positive’, ‘false positive’ etc.) for each con-
dition for onward analysis of wellbeing, rather than to define
cases per se. Separate case counts were extracted based on
whether identified from GP or hospital records, or both.
From the contingency matrices epidemiological measures
such as specificity, sensitivity, positive predicted value (PPV)
and negative predictive value (NPV) were calculated for each
condition based on clinical data as the ‘gold standard’. Indica-
tive prevalence values were calculated with associated con-
fidence intervals (CIs) along with Cohen’s Kappa statistics
based on valid responses only (excluding counts for ‘No an-
swer/refused’ responses).
Results
Sample Characteristics
With consent for data linkage introduced part-way through
2013 onwards, the numbers of adult with matched health
records were 4,362 for 2013 (29.1% of those sampled) and
7,332 for 2014 (51.7% of those sampled). This provided a
combined study population of 11,323, for which Table 1 shows
the age and gender characteristics. More than half of the sam-
ple population was aged over 45, with more females than males
for all age groups except 60-74.
Identified Cases
For asthma, more cases were identified from clinical data than
were reported by the WHS (see Table 2). For cardiovascular
conditions fewer cases were identified from clinical data com-
pared to the WHS, and considerably so (thereby contributing
to the variation in PPV values shown in Table 3). Also no-
table from Table 2 is that for asthma the vast majority of
cases were identified from GP events whereas for cardiovas-
cular conditions most were identified via a hospital diagnosis.
For ‘currently being treated’ conditions less than 10 percent
of cases were identified by both a GP event and hospital diag-
nosis, whereas over a fifth of ‘ever treated’ heart attack cases
were identified in this way. Given that the GP data used cov-
ered 80 percent of practitioners, identified case counts could
be estimated to be six to eight cases higher for cardiovascular
conditions and 269 higher for asthma based on GP records
only, though some of these will instead have been picked up
through hospital records.
Tables 3-6 show the validation results for the selected
chronic conditions.
Table 7 summarises the epidemiological measures for each
condition. Relative prevalence levels calculated using survey
and clinical data are shown, along with Cohen’s Kappa statis-
tics.
Specificity and NPV were high for all conditions, with
NPVs in excess of 99 percent for cardiovascular conditions.
By contrast, sensitivity varied from 50 percent for heart fail-
ure (currently treated) to 75 percent for heart attack (ever
treated). The PPV for asthma was notably higher than for
cardiovascular conditions.
For cardiovascular conditions there were significant differ-
ences in indicative prevalence when based on survey vs. clini-
cal data, ranging from around 10 cases per thousand to over
40 cases per thousand for heart attack. Whether conditions
were ‘currently treated’ or ‘ever treated’ made no difference to
the disparity in relative prevalence based on the two sources.
For cardiovascular conditions indicative prevalence was con-
siderably higher based on survey data compared to clinical
data. The divergence in indicative prevalence is reflected in
the Kappa statistics which show poor agreement between the
two data sources.
For asthma there was no significant difference in indicative
prevalence based on the survey vs. clinical data. In addition,
the Kappa statistic indicates a fair to good agreement between
the data sources.
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Figure 1: Data Linkage Using Anonymised Data in SAIL
Table 1: Characteristics of WHS Sample with Consent and Successful Data Linkage, 2013 and 2014 Combined
n (% of Column)
Age Group Males Females Total
16-29 731 (13.9) 1,014 (16.7) 1,745 (15.4)
30-44 935 (17.8) 1,229 (20.2) 2,164 (19.1)
45-59 1,304 (24.9) 1,559 (25.6) 2,863 (25.3)
60-74 1,565 (29.8) 1,543 (25.4) 3,108 (27.4)
75+ 709 (13.5) 734 (12.1) 1,443 (12.7)
All ages 5,244 6,079 11,323
(% of Row) (46.3) (53.7)
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Table 2: Chronic Condition Cases Identified by GP Event and/or Hospital Diagnosis
Condition Identified by Count % of Total
Angina - Currently being treated
GP Records 32 26
Hospital Diagnosis 84 68
Both GP Event and Hospital Diagnosis 8 6
Total from Clinical data 124
Total from WHS 396
Heart Attack – Ever been treated
GP Records 21 18
Hospital Diagnosis 68 60
Both GP Event and Hospital Diagnosis 25 22
Total from Clinical data 114
Total from WHS 473
Heart Failure - Currently being treated
GP Records 28 38
Hospital Diagnosis 39 53
Both GP Event and Hospital Diagnosis 6 8
Total from Clinical data 73
Total from WHS 191
Asthma - Currently being treated
GP Records 1,079 86
Hospital Diagnosis 80 6
Both GP Event and Hospital Diagnosis 97 8
Total from Clinical data 1,256
Total from WHS 1,173
Table 3: Respondents ‘Currently’ Treated for Angina at Time of Survey based on WHS and Clinical data
Survey Clinical data
Yes No Total
Yes 77 319 396
of which:
Female (%) (42.9) (43.3) (43.2)
Male (%) (57.1) (56.7) (56.8)
No 38 10,329 10,367
of which:
Female (%) (21.1) (54.0) (53.9)
Male (%) (78.9) (46.0) (46.1)
No answer/ refused 560
Total 11,323
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Table 4: Respondents Ever Treated for Heart Attack based on WHS and Clinical data
Survey Clinical data
Yes No Total
Yes 82 391 473
of which:
Female (%) (35.4) (33.2) (33.6)
Male (%) (64.6) (66.8) (66.4)
No 27 10,359 10,386
of which:
Female (%) (63.0) (54.5) (54.5)
Male (%) (37.0) (45.5) (45.5)
No answer/ refused 464
Total 11,323
Table 5: Respondents ‘Currently’ Treated for Heart Failure at Time of Survey based on WHS and Clinical data
Survey Clinical data
Yes No Total
Yes 33 158 191
of which:
Female (%) (30.3) (37.3) (36.1)
Male (%) (69.7) (62.7) (63.9)
No 33 10,468 10,501
of which:
Female (%) (42.4) (53.8) (53.8)
Male (%) (57.6) (46.2) (46.2)
No answer/ refused 631
Total 11,323
Table 6: Respondents ‘Currently’ Treated for Asthma at Time of Survey based on WHS and Clinical data
Survey Clinical data
Yes No Total
Yes 818 355 1,173
of which:
Female (%) (61) (58) (60)
Male (%) (38) (42) (40)
No 370 9,220 9,590
of which:
Female (%) (53) (53) (53)
Male (%) (47) (47) (47)
No answer/ refused 560
Total 11,323
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Table 7: Respondents ‘Currently’ Treated for Asthma at Time of Survey based on WHS and Clinical data
Percentages Prevalence per 1,000 from Kappa
Sensitivity Specificity PPV NPV Clinical data Survey Statistic
Angina – Currently being treated 66.96 97 19.44 99.63 11 35 0.290
(CIs) (9/13) (32/38)
Heart Attack – Ever been treated 75.23 96.36 17.34 99.74 10 42 0.270
(CIs) (8/12) (38/45)
Heart Failure – currently being treated 50 98.51 17.28 99.69 6 17 0.250
(CIs) (5/8) (15/19)
Asthma – currently being treated 68.86 96.29 69.74 96.14 105 104 0.655
(CIs) (99/111) (98/109)
Missing Data
For the WHS questions on asthma and cardiovascular condi-
tions non-response was between four and five percent overall
(see Table 8), and slightly lower for heart attack (‘ever been
treated’) than ‘currently being treated’ conditions. The is-
sue of missing data and intentional non-response is discussed
further below.
Discussion
Linking health survey, GP and hospital data was relatively
straightforward and generated an extensive and expedient
dataset for survey validation purposes. Crosstabulation was
similarly uncomplicated using the statistical software available
in the secure environment provided by the databank.
The validation results for some of the selected conditions
are disappointing. In particular the PPV results achieved for
cardiovascular conditions (17-19 percent) are low compared to
those for asthma, and applying the method for separate car-
diovascular conditions was less successful as it was not possi-
ble to use medication codes to distinguish between them. As
a consequence, there were significant differences in indicative
prevalence for cardiovascular conditions based on the two data
sources. Although the sets of ICD and Read codes used were
developed with expert advice from a clinician, the result was
low PPV levels for separate cardiovascular conditions. An al-
ternative approach may have been to validate positive cardio-
vascular cases from the survey against occurrence of relevant
codes in clinical data, then with the results for each condition
use machine learning to identify non-self-reporting cases in the
remaining data. This would have been more time-consuming
but also possibly more effective in identifying those not self-
reporting their condition.
The method was more effective for asthma, with a PPV of
nearly 70 percent and evidence of better agreement between
the data sources, possibly due to better diagnosis and/or more
clearly defined interventions for asthma. Most of the difference
though is understood to be due to the use of medication codes
to identify cases as an initial test run without them yielded a
PPV below those for cardiovascular conditions. This indicates
that GP read code lists need to include those for medications
to identify cases, whether cardiovascular or asthma-related.
These results show that it is possible to use an algorithm to
identify chronic disease prevalence from EHRs, but on a qual-
ified basis, e.g. where a list of medication codes are available
to identify cases. Further, it is possible to use a data link-
ing method to validate population health survey - with clinical
data for chronic conditions, but relative prevalence can vary
widely depending on how the conditions are defined. So a
data linking method may feasibly be used to estimate preva-
lence in the absence of a disease register. Where a generally
accepted and definitive code list does not exist for a condi-
tion, considerable variation in prevalence may be expected.
Further, datasets may variously be more suitable for identify-
ing specific chronic conditions e.g. GP rather than hospital
records for asthma, as shown in Table 2. This may be due
to the way medications for such conditions are coded by GPs.
Equally, the method applied did not utilise data from specialist
physician or outpatient departments and closer agreement in
prevalence may be possible if such data were included. This
may particularly be the case for cardiovascular conditions.
By extension, EHRs may not always be a ‘gold standard’
for validating prevalence of chronic conditions depending on
whether the available data extends beyond just GP and hospi-
tal admission records. Results may also be affected by survey
questions, which in this case required respondents and the re-
searcher alike to surmise the meaning of ‘currently treated’ for
some conditions and ‘ever treated’ for another. Lower PPV
results for all ‘currently treated’ conditions compared to ‘ever
treated’ for heart attack from the same survey may be due to
additional cognitive bias via the telescoping effect (whereby re-
mote events appear to have occurred more recently), leading
to a tendency to over-report over the short term. From this
it could be argued that where linkage and validation of survey
and clinical data is expected then survey questions on morbidi-
ties should perhaps be in terms of whether treated in the last
12 months as recommended by some for hospitalizations [10].
This would enable clearer definition of recall required from re-
spondents and of the lookback period required for data linking
purposes.
This study used a single record from either GP or hospi-
tal data to identify cases. The aim of this approach was to
define subgroups for each condition (true positives, false pos-
itives etc.) to enable onward analysis of relative wellbeing.
Arguably a more generally acceptable case definition could
be applied based on a minimum of two GP visits or a hos-
pitalisation. Previous case definition work has indicated that
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Table 8: Non-Response to Selected Chronic Condition Questions, Matched WHS Records, 2013 and 2014
WHS question All Survey RespondentsCount Percentage
Angina – Currently being treated 560 4.95
Heart Attack – Ever been treated 464 4.10
Heart Failure – Currently being treated 631 5.57
Asthma – Currently being treated 560 4.95
agreement between data sources varies across chronic condi-
tions and that a common approach does not necessarily exist
[11]. The results of this study are consistent with these find-
ings, although perhaps less clear-cut due to the variation in
survey questions used to define the conditions. It is possible
that any decrease in cases identified using the more stringent
definition may be mitigated when validating for those ‘ever
treated’. Equally, it could be argued that if access to specific
data is limited then case identification could be implemented
based solely on GP records for asthma and just hospital data
for the most severe cardiovascular conditions.
Improved criterion validity of survey data for cardiovascu-
lar conditions could be obtained if validation was applied for
heart failure singly and for ischaemic heart disease as a group
(to cover angina and ‘heart attack’ as recorded by the WHS).
Some studies have shown that medication codes have been
used to identify cardiovascular conditions collectively but not
separately [12], and treated them as a grouped predictor for
medical expenditure [13]. Other studies have found substan-
tial under-recording of chronic conditions [14, 15] and recom-
mended the use of prescription medication data to improve
case identification for heart failure [14]. On the other hand,
others have found that use of prescription data did not sig-
nificantly improve the agreement between clinical and survey
data when used to define cases for heart disease [11]. A sys-
tematic review has indicated that validation of morbidity is
more likely to be provided by conventional chart review than
administrative data [16].
This study indicates significant differences in prevalence
estimates for distinct cardiovascular conditions when based
on survey and clinical datasets. By contrast, prevalence esti-
mates for asthma were closely matched. The asthma findings
are consistent with those from a survey of 27 asthma-related
datasets which indicated UK-level prevalence of 9.6 percent
for patient reported clinician-diagnosed-and-treated asthma at
2010-11 [17]. For cardiovascular conditions a similar level of
specificity has been found for heart disease as a group, with
a higher PPV but lower sensitivity and lower NPV [18]. Low
kappa statistic values have also been found when comparing
survey and admin for heart failure (‘ever treated’) [19], al-
though not as low as those found in this study (‘currently
being treated’).
This study indicates that there were low levels of missing
data for the paper-based WHS, and it could be argued that
this slightly undermined the WHS as a measurement tool for
prevalence of chronic conditions. Given the proximity of the
estimates for asthma it could be argued that the issue of non-
response would be avoided completely if prevalence was based
on clinical rather than health survey data.The data linking
method advocated though enables all available WHS records
to be linked with analagous clinical data, regardless of non-
response to specific questions so that in principle it is possible
to establish ‘true’ prevalence for some conditions using clinical
data. Alternatively, by using the data linkage and matching
method presented above it may be possible to improve the ac-
curacy of prevalence estimates by augmenting survey estimates
with clinical data, as suggested by others [21]. On the other
hand this may appear to sidestep intentional non response for
the sake of improved statistical quality.
A more fundamental question is whether population sur-
veys or clinical data should be used to estimate prevalence of
chronic conditions. Since clinical data can now be warehoused
and regularly updated it could be argued that surveys are du-
plicating clinical data collection for some health conditions.
With potentially lengthy interviews of over 30 minutes, sur-
vey time could easily be freed up to explore qualitative health
issues or other policy issues if self-reported health questions
were removed. Alternatively, surveys could be shorter overall
to avoid bias due to response fatigue.
Strengths and limitations
Relatively few studies apply a data linking approach with clini-
cal data and cross-sectional patient-reported information, and
such studies tend to be based on data from the USA and
elsewhere [15, 21-25]. A strength of this study is that it is
fairly unique in applying a data linking approach to UK-based
health survey data. This approach has been suggested and
recommended by others in the past [26, 27]. Other strengths
are that this study is based on national-level survey data and
demonstrates a methodological approach to validating popu-
lation health survey data using data linkage.
This study has some limitations. As obtaining consent
to data linkage was introduced part way through the 2013
tranche of the WHS, results are based on a 21-month report-
ing period (i.e. April 2013 to December 2014) rather than two
complete years’ worth of data. The sample may be affected
by selection bias as some population groups may more readily
have given consent than others based on relative awareness
of how their data would be used pre-GDPR (General Data
Protection Regulation). Also at the time of the analysis the
WLGP dataset comprised data from around 80 percent of GP
practices in Wales, and a small number of cardiovascular cases
were identified based on just GP data events, so some results
(i.e. observed prevalence) may differ slightly if data for all GP
practices were utilised. The availability of specialist physician
data would also potentially be helpful. The generalisability
of the results at a national level may also be limited by the
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sample size and possible reporting bias, as already highlighted.
Population health surveys, now utilise Computer Assisted Per-
sonal Interview (CAPI) and Computer Assisted Self Interview-
ing (CASI) so that the applicability of some findings may be
limited.
Conclusion
This study set out to develop an approach to disease ascertain-
ment for chronic conditions not recorded by clinical registries
in Wales. Results indicate that there are inherent limitations
in survey and clinical datasets and ultimately it is difficult to
determine whether either should be considered as a gold stan-
dard for the estimation of prevalence.
A data linking method may feasibly be used to estimate
prevalence for some chronic conditions in the absence of a dis-
ease register, but data from specialist physician or outpatient
departments may be required to obtain reasonable estimates.
The results also indicate the method provides better agree-
ment between data sources where prescribed medications can
be used to identify conditions. Plausible sets of clinical codes
which include medications are required to identify and validate
chronic conditions in linked clinical data.
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